Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis; 9 (2013):159.
https://asmbs.org/wp/uploads/2014/05/AACE_TOS_ASMBS_Clinical_Practice_Guidlines_3.2013.pdf. Accessed July 2016.
US Department of Health and Human Services. National Institute of Diabetes and Digestive and Kidney Diseases. Bariatric surgery for severe obesity. https://www.niddk.nih.gov/health-information/health-topics/weight-control/bariatric-surgery-severe-obesity/Pages/bariatric-surgery-for-severe-obesity.aspx. Updated June 2011. Accessed July 2016.
Sabiston D. 2012. Morbid obesity. In Sabiston Textbook of Surgery the Biological Basis of Modern Surgical Practice (19th ed., pp. 358-388). Philadelphia, PA: Elsevier Saunders.
US Department of Health & Human Services. Agency for Healthcare Research and Quality. National and regional estimates on hospital use for all patients from the HCUP nationwide inpatient sample. http://hcupnet.ahrq.gov/HCUPnet.jsp. 2012. Accessed July 22, 2014.
Bariatric surgery. Obesity Action Coalition. http://www.obesityaction.org/obesity-treatments/bariatric-surgery. Accessed July 2016.
US Department of Health and Human Services. US Food and Drug Administration. ORBERA intragastric balloon system – P14008. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm457416.htm. Updated August 6, 2015. Accessed July 2016.
Schachter H. Vagal nerve blockade for obesity: VBLOC therapy using maestro RC2 device. Canadian Agency for Drugs and Technology in Health (CADTH). https://www.cadth.ca/vagal-nerve-blockade-obesity-vbloc-therapy-using-maestro-rc2-device. October 2015. Accessed July 2016.